New glaucoma test set to roll out
A $304,000 State Government seed grant will be used to commercialise a pioneering solution for assessing glaucoma risk in clinical settings. South Australian company Seonix Bio […]
A $304,000 State Government seed grant will be used to commercialise a pioneering solution for assessing glaucoma risk in clinical settings. South Australian company Seonix Bio […]